Response to Heard et al.

EMBO Journal

Volumn 34, Issue 19, 2015, Pages 2396-

  Moulin, Maryline ^a   Voss, Anne K ^b,c   Thomas, Tim ^b,c   Wong, Wendy Wei Lynn ^d   Cook, Wendy D ^e   Koentgen, Frank ^f   Vince, James ^b,c   Silke, John ^b,c   Vaux, David L ^b,c  

^a INSERM   (France)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e LA TROBE UNIVERSITY   (Australia)

^f Ozgene Pty Ltd   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CIAP1 PROTEIN; CIAP2 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; INHIBITOR OF APOPTOSIS PROTEIN; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; TUMOR NECROSIS FACTOR RECEPTOR 1;

CHROMOSOME; EMBRYO CELL; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; FIBROBLAST; HOMOLOGOUS RECOMBINATION; HUMAN; IMMORTALIZED CELL LINE; LETTER; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; START CODON; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; FEMALE; MALE; METABOLISM;

ANIMALS; FEMALE; INHIBITOR OF APOPTOSIS PROTEINS; MALE; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 84942772742     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.15252/embj.201592761     Document Type: Letter

References (13)

1. Conze DB, Albert L, Ferrick DA, Goeddel DV, Yeh WC, Mak T, Ashwell JD, (2005) Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol Cell Biol 25: 3348-3356
2. Cook WD, Moujalled DM, Ralph TJ, Lock P, Young SN, Murphy JM, Vaux DL, (2014) RIPK1- and RIPK3-induced cell death mode is determined by target availability. Cell Death Differ 21: 1600-1612
3. Darding M, Feltham R, Tenev T, Bianchi K, Benetatos C, Silke J, Meier P, (2011) Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2. Cell Death Differ 18: 1376-1386
4. Gardam S, Turner VM, Carter H, Limaye S, Basten A, Koentgen F, Vaux DL, Silke J, Brink R, (2011) Deletion of cIAP1 and cIAP2 in B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. Blood 117: 4041-4051
5. Heard KN, Bertrand MJM, Barker PA, (2015) cIAP2 supports viability of mice lacking cIAP1 and XIAP. EMBO J 34: 2393-2395
6. Kenneth NS, Younger JM, Hughes ED, Marcotte D, Barker PA, Saunders TL, Duckett CS, (2012) An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1. Biochem J 443: 355-359
7. Koentgen F, Suss G, Stewart C, Steinmetz M, Bluethmann H, (1993) Targeted disruption of the Mhc class-Ii Aa gene in C57bl/6 mice. Int Immunol 5: 957-964
8. Lawlor KE, Khan N, Mildenhall A, Gerlic M, Croker BA, D'Cruz AA, Hall C, Kaur Spall S, Anderton H, Masters SL, Rashidi M, Wicks IP, Alexander WS, Mitsuuchi Y, Benetatos CA, Condon SM, Wong WW, Silke J, Vaux DL, Vince JE, (2015) RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL. Nat Commun 6: 6282
9. Moulin M, Anderton H, Voss AK, Thomas T, Wong WW, Bankovacki A, Feltham R, Chau D, Cook WD, Silke J, Vaux DL, (2012) IAPs limit activation of RIP kinases by TNF receptor 1 during development. EMBO J 31: 1679-1691
10. Vanden Berghe T, Hulpiau P, Martens L, Vandenbroucke RE, Van Wonterghem E, Perry SW, Bruggeman I, Divert T, Choi SM, Vuylsteke M, Shestopalov VI, Libert C, Vandenabeele P, (2015) Passenger mutations confound interpretation of all congenic knockout mice. Immunity 43: 200-209
11. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ, Flygare JA, Fairbrother WJ, Deshayes K, Dixit VM, Vucic D, (2007) IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131: 669-681
12. Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, Benetatos CA, Chunduru SK, Condon SM, McKinlay M, Brink R, Leverkus M, Tergaonkar V, Schneider P, Callus BA, Koentgen F, Vaux DL, Silke J, (2007) IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131: 682-693
13. Wong WW, Vince JE, Lalaoui N, Lawlor KE, Chau D, Bankovacki A, Anderton H, Metcalf D, O'Reilly L, Jost PJ, Murphy JM, Alexander WS, Strasser A, Vaux DL, Silke J, (2014) cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1- and RIPK3-dependent manner. Blood 123: 2562-2572